Ocular Therapeutix OCUL
NASDAQ OCUL
$6.58 +0.10 (+1.55%)
As of: Oct 22, 2026 · 11:37 AM EDT

Ocular Therapeutix (OCUL) Preferred Shares (2013)

Updated

Ocular Therapeutix (OCUL) posted Preferred Shares of $8.49 million for Q4 2013.

Analysis

Ocular Therapeutix (OCUL) Preferred Shares (2013) Analysis & Trends

  • In prior years, Ocular Therapeutix's Preferred Shares was $23.78 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn -
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn -
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn -
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn -
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn -
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn -
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn -
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn -
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn -
10 Ocular Therapeutix 1.48 Bn -866.92 Mn 11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 8.49 Mn
API Access

Ocular Therapeutix Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=OCUL&period=max&api_key=YOUR_API_KEY